In a small trial all 18 people with rectal cancer
who received a drug called Dostarlimab went into remission. It is
the first time that a cancer drug was 100 percent successful in a
trial. More research is needed.
Contact: info@neat-news.com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
The page is maintained in Germany and for any legal matters the laws of Germany apply.
Any warranty or liability is excluded in the widest legally possible sense.